Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FTY720 introduction and calcineurin inhibitor elimination in maintenance renal transplant recipients
2004-000655-41Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fingolimod, sponsored by Novartis. Started Dec 2005; status: completed.
02
Drugs
fingolimod
Beyond the preview
Go deeper on 2004-000655-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000655-41.